CPS1 and hepatocellular carcinoma: CPS1 was discovered as the target of the hepatocyte paraffin 1 (HepPar1) antibody [12], which is most often used by pathologists to differentiate hepatocellular carcinoma from metastases, as it is highly expressed in cells of hepatocellular origin, whereas other organs only show low expression levels [13].